Jacob M. van Laar, Dominique Farge, Jacob K. Sont, Kamran Naraghi
Importance High-dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small phase 2 trials.
Objective To compare efficacy and safety of HSCT vs 12 successive monthly intravenous pulses of cyclophosphamide.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados